Why Tenet Healthcare Is a Buy - Zacks.com
Tent Healthcare has been witnessing rising earnings estimates on the back of a couple of encouraging announcements by the company. These include Tent Healthcare’s acquisition plans, partnerships and geographic expansions. Earlier, the company had reported impressive first-quarter 2014 results that drove bullish sentiment on the stock and upward estimate revision.
...
With regard to partnerships, Tenet Healthcare’s alliance with Texas Tech University Health Sciences Center at El Paso in May 2014 to set up a teaching hospital is impressive. Moreover, the ACO agreement with Florida Blue in Jun 2014 and collaboration with Cigna Corp. (CI - Analyst Report) in May 2014 are noteworthy for triggering bullish sentiment.
Read the full story >>
Related Stories
38th Student Research Week Successful at Showcasing Secrets of Immune Defense
Student researchers at TTUHSC had the opportunity to showcase their presentation skills at the 38th Annual Student Research Week Feb. 25 – 27.
Celebrating Veterans: TTUHSC’s General Martin Clay’s Legacy of Service and Leadership
From his initial enlistment in the Army National Guard 36 years ago to his leadership in military and civilian health care management roles, Major General Martin Clay’s career has been shaped by adaptability, mission focus and service to others.
Texas Tech University Health Sciences Center School of Nursing Named Best Accelerated Bachelor of Science in Nursing Program in Texas
The TTUHSC School of Nursing Accelerated Bachelor of Science in Nursing (BSN) program has been ranked the No. 1 accelerated nursing program in Texas by RegisteredNursing.org.
Recent Stories
TTUHSC Recognized for Commitment to Improving Experiences and Advancing Outcomes for First-Generation College Students
FirstGen Forward announced TTUHSC is a new member of the FirstGen Forward Network Class of 2026. FirstGen Forward selected TTUHSC because the university demonstrated a commitment to improving experiences and advancing success for first-generation college students.
TTUHSC Researchers Collaborate in Study of Cancer Drug’s Possible Positive Effects on Alzheimer’s Disease
A drug typically used to treat some forms of cancer may also help delay the progression of Alzheimer’s disease. Boris Decourt, Ph.D., director of the TTUHSC Laboratory on Neurodegeneration and Translational Research, is part of the Phase II trial.
TTU System Board of Regents Approves Appointment of Grover E. Murray Professor
The Texas Tech University System Board of Regents today (Aug. 13) approved the appointment of Rodney Young, M.D., from the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine, as a Grover E. Murray Professor.